BOOTHBAY FUND MANAGEMENT, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$557,000
+139.1%
20,619
+146.8%
0.01%
+133.3%
Q3 2021$233,000
-15.0%
8,355
-9.5%
0.01%
-33.3%
Q2 2021$274,000
-30.6%
9,228
-41.3%
0.01%
-62.5%
Q3 2020$395,000
-15.6%
15,718
-18.1%
0.02%
-25.0%
Q2 2020$468,000
+32.2%
19,180
-19.7%
0.03%
+10.3%
Q1 2020$354,000
-49.5%
23,900
-44.7%
0.03%
-52.5%
Q4 2019$701,000
+109.3%
43,200
+297.1%
0.06%
+52.5%
Q1 2018$335,00010,8780.04%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders